Peptide Blog
Articles, dosing guides, and expert insights on peptides and their real-world applications.
FDA Peptide Vote 2026: 6 of 7 Backed for Compounding
FDA advisers backed BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax while rejecting Emideltide/DSIP. See every tally, what the non-binding recommendations mean, and what FDA does next.
Retatrutide Phase 3 Results: 22.6% Weight Loss and a 2027 FDA Filing
Eli Lilly’s latest retatrutide Phase 3 results show up to 22.6% average weight loss in TRIUMPH-3 and 20.8% in TRIUMPH-2. Here is what the topline data, cardiovascular findings, side effects, and planned Q1 2027 FDA filing mean.
MEDVi Reviews 2026: Pricing, Complaints & Is It Legit?
MEDVi reviews 2026: 4.4/5 on Trustpilot but an F rating and 668 complaints at the BBB. Real pricing ($179 then $299), patient results, the FDA letter, and how to cancel.
How to Increase IGF-1 Naturally: Diet, Exercise & Lifestyle (2026)
How to increase IGF-1 naturally with protein, resistance training, deep sleep and key nutrients, backed by what human studies actually show (2026).
HRT for Women: Benefits, Risks, and Who It's Right For
An honest, current guide to HRT for women: the two main types, real risk numbers, the 2025 FDA warning change, who it fits by age, alternatives, and how to get it.
MOTS-c vs SS-31 (Elamipretide): Which Mitochondrial Peptide Is Right for You? (2026)
MOTS-c and SS-31 are both called mitochondrial peptides, but they do nearly opposite things: MOTS-c signals cells to act like they are exercising, while SS-31 (elamipretide) physically repairs the inner mitochondrial membrane. This guide compares mechanism, evidence, dosing, and safety, including SS-31's landmark 2025 FDA approval.
Reader discount
99%+ purity research peptides — third-party tested, COA included
Save 50% with code PEPTIDEDECK
Botox-Alternative Peptides: Syn-Ake, Leuphasyl & Vialox Explained (2026)
Syn-Ake, Leuphasyl (pentapeptide-18), and Vialox (pentapeptide-3v) are marketed as needle-free 'topical Botox' peptides. This guide breaks down how each one targets the acetylcholine pathway, what the published wrinkle data actually show, and why skin penetration limits how well any of them works compared to a real botulinum toxin injection.
Zepbound Before and After: Real Results, Weight Loss Timeline & Reviews (2026)
What does Zepbound (tirzepatide) actually do over 72 weeks? This guide replaces hype photos with published SURMOUNT trial data: a month-by-month timeline, an effect-size table in real pounds and kilograms, the head-to-head vs Wegovy, and what happens to your results if you stop.
Tesamorelin + Ipamorelin Stack: Blend Protocol, Dosing & Synergy (2026)
The tesamorelin ipamorelin stack pairs an FDA-approved GHRH analog with a selective ghrelin-receptor GHRP that act on two different switches in the growth hormone axis. This guide covers the synergy mechanism, dosing math, what the human trial data actually shows for each peptide, and the safety questions and contraindications behind the blend.
PP405: The Topical Hair-Loss Drug Targeting Follicle Stem Cells (2026)
PP405 is an experimental once-daily topical gel for pattern hair loss that reprograms follicle stem cell metabolism to wake dormant follicles. We cover how it works, what its Phase 2a trial actually showed, how it compares to minoxidil and finasteride, and a realistic access timeline.